Movement Alert|Nutanix Inc. Rises 10.49% in Regular Trading, Q4 Revenue Beats Expectations with Optimistic FY2027 Guidance

Market Focus
Aug 27

On August 27, Nutanix Inc. rose 10.49% in regular trading, trading at $73.62/share, with turnover of $21.74 million.

On the news front, the company reported FY2026 Q4 revenue of $757.1 million, exceeding the consensus estimate of $738.3 million and representing approximately 16% year-over-year growth. Adjusted gross margin reached 87.7%. However, adjusted EPS of $0.13 fell short of the $0.49 estimate, though investors appeared to prioritize the top-line momentum.

The company issued FY2027 Q1 revenue guidance of $755 million to $765 million and full-year guidance of $3.18 billion to $3.23 billion, both above the Wall Street consensus of $3.20 billion. Concurrently, Nutanix launched its Enterprise AI 2.8 platform upgrade, reinforcing its enterprise-grade Agentic AI strategy. Following the results, RBC raised its price target to $90 from $84 maintaining an Outperform rating, while UBS previously raised its target to $80 from $62 with a Buy rating, citing a 40%-50% pipeline increase driven by VMware migrations.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10